- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04947332
Auto-inoculation of a Wart in Multiple Viral Warts
January 12, 2022 updated by: Muhammad Waseem Shahid, Pak Emirates Military Hospital
Effectiveness of Auto-inoculation of a Wart in Multiple Viral Warts, in Tertiary Care Hospital : A Single Arm Study
This study is being conducted to see effectiveness of auto-inoculation of a wart in multiple viral warts.
Patients with recurrent, multiple warts of all types, are being recruited for the study.
A wart is excised, minced and then inoculated in a subcutaneous pocket made on the volar aspect of forearm.
Patients are to be reviewed after every 4 weeks to note any reduction in number warts.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
A single arm, Phase 1, Clinical Study
Study Type
Interventional
Enrollment (Anticipated)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Waseem Shahid, MBBS
- Phone Number: +923347202392
- Email: waseem902@yahoo.com
Study Locations
-
-
Punjab
-
Rawalpindi, Punjab, Pakistan
- Recruiting
- Pak Emirates military hospital
-
Contact:
- Muhammad W Shahid, MBBS
- Phone Number: +923347202392
- Email: waseem902@yahoo.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Individuals having 5 or warts
- Individuals having any types of warts
Exclusion Criteria:
- Individuals using any other treatment for warts
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Auto-inoculation recipients
Auto-inoculation of wart to be performed
|
A wart will be excised from the body, minced and will be inoculated in a subcutaneous pocket on forearm.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Complete Clearance of Warts
Time Frame: 12 weeks
|
All the warts on any part of the body are cleared
|
12 weeks
|
Incomlete Clearance of Warts
Time Frame: 12 weeks
|
No or size of warts are reduced
|
12 weeks
|
Non Responders
Time Frame: 12 weeks
|
If no change or increased no of warts
|
12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Nadia Iftikhar, MBBS, FCPS, head of department
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 8, 2021
Primary Completion (Anticipated)
January 31, 2022
Study Completion (Anticipated)
February 10, 2022
Study Registration Dates
First Submitted
June 19, 2021
First Submitted That Met QC Criteria
June 23, 2021
First Posted (Actual)
July 1, 2021
Study Record Updates
Last Update Posted (Actual)
January 13, 2022
Last Update Submitted That Met QC Criteria
January 12, 2022
Last Verified
January 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- A/28/EC/230/2021
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Viral Wart
-
Minneapolis Veterans Affairs Medical CenterMinnesota Medical FoundationCompletedPlantar Wart | Wart | Common Wart | Verruca Vulgaris | Verruca PlantarisUnited States
-
Labo'LifeRecruitingPlantar Wart | Common Wart | Flat WartBelgium
-
Karo Pharma ABCompletedPlantar Wart | Common WartPoland
-
Assiut UniversityCompletedPlantar Wart | Common WartEgypt
-
Combined Military Hospital AbbottabadCompleted
-
University of Illinois at ChicagoNot yet recruiting
-
Rambam Health Care CampusCompleted
-
Swiss Footcare Laboratories - Poderm ProfessionalRecruitingWarts | Plantar Wart | Common WartTunisia
-
Aljazeera HospitalNational Research Centre, EgyptUnknown
-
Aclaris Therapeutics, Inc.Completed
Clinical Trials on Auto-inoculation
-
Liverpool University Hospitals NHS Foundation TrustLiverpool School of Tropical Medicine; Sponsor GmbHCompletedPneumonia | Influenza, HumanUnited Kingdom
-
Beijing Center for Disease Control and PreventionCompleted
-
Royal Cornwall Hospitals TrustEnrolling by invitationStress | Stress, Psychological | Stress, JobUnited Kingdom
-
Ottawa Hospital Research InstituteUniversity of TorontoCompleted
-
Center for Vaccine Development - MaliUniversity College, London; University of Oxford; Public Health England; University... and other collaboratorsRecruitingMeningitis, MeningococcalMali
-
Shandong Province Centers for Disease Control and...Hunan Provincial Center for Disease Control and Prevention; Shaanxi Provincial...UnknownEnterovirus 71 Inactivated Vaccine | HFMDChina
-
Philips RespironicsCompletedObstructive Sleep ApneaUnited States, Germany
-
Philips RespironicsCompletedSleep Disordered Breathing | Sleep Apnea, CentralUnited States
-
Seigo NishidaFlorida Department of HealthCompletedLiver Cirrhosis | Hepatocellular Carcinoma | Evidence of Liver TransplantationUnited States
-
Guangdong Provincial People's HospitalWithdrawnVaccine Adverse Reaction | Lung Cancer | COVID-19 Pneumonia | SARS-CoV-2 Acute Respiratory Disease | Pulmonary Nodule, Solitary | Pulmonary Nodule, MultipleChina